Status:
COMPLETED
Toradol (Ketorolac) in Breast Surgery to Reduce Pain & Opioid Use
Lead Sponsor:
Carilion Clinic
Conditions:
Breast Reduction
Breast Reconstruction
Eligibility:
FEMALE
18-64 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to investigate whether perioperative single-dose administration of ketorolac (Toradol) can reduce post-operative pain after breast surgery, thereby decreasing post-operati...
Detailed Description
The investigators will perform a double blinded, prospective randomized trial of perioperative ketorolac (Toradol) on breast reduction and breast reconstruction procedures. Patients will be randomized...
Eligibility Criteria
Inclusion
- Patient consents to study
- Adult females needing breast reconstruction or breast reduction (day surgeries)
Exclusion
- Patients with known kidney disease
- Patient does not consent
- patients with history of bleeding disorder, peptic ulcer disease, renal disease, blood thinners use, bariatric surgery and any other contraindications of Toradol use
- patients currently taking aspirin
- pregnant women (not standard to operate on this population anyway)
Key Trial Info
Start Date :
June 22 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2023
Estimated Enrollment :
183 Patients enrolled
Trial Details
Trial ID
NCT04439396
Start Date
June 22 2020
End Date
January 30 2023
Last Update
February 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
James T. Thompson
Roanoke, Virginia, United States, 24016